Progenics Pharmaceuticals, Inc. is now a
subsidiary of Lantheus Holdings, Inc.
Investors Investors

Proxy Materials

Proxy Materials

Special Meeting Regarding Proposed Merger with Lantheus

Title Documents

Proxy Statement – Special Meeting

Supplement to Proxy Statement – Special Meeting

2019 Annual Meeting Materials

Title Documents

Annual Report

Notice and Proxy Statement

Letter to Shareholders – June 3, 2019

Letter to Shareholders – June 13, 2019

Letter to Shareholders – June 19, 2019

Investor Presentation – June 20, 2019

Investor Presentation – June 24, 2019

Shareholder Retail Brochure – June 28, 2019